NCT02624505View on ClinicalTrials.gov

Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions
Bronchial Asthma
Interventions
DRUG

90 mcg Reference Product

Drug: 90 mcg Reference Product

DRUG

180 mcg Reference Product

Drug: 180 mcg of Reference Product

DRUG

90 mcg Test Product

Drug: 90 mcg of Test Product

DRUG

Placebo

Placebo Product

Trial Locations (1)

80230

Colorado Allergy and Asthma Centers, Denver

All Listed Sponsors
lead

Cipla Ltd.

INDUSTRY

NCT02624505 - Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma | Biotech Hunter | Biotech Hunter